Terms: = Gastric cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Treatment
4 results:
1. Defective migration and dysmorphology of neutrophil granulocytes in atypical chronic myeloid leukemia treated with ruxolitinib.
Bornemann L; Schuster M; Schmitz S; Sobczak C; Bessen C; Merz SF; Jöckel KH; Haverkamp T; Gunzer M; Göthert JR
BMC Cancer; 2020 Jul; 20(1):650. PubMed ID: 32660441
[TBL] [Abstract] [Full Text] [Related]
2. Stromal score as a prognostic factor in primary gastric cancer and close association with tumor immune microenvironment.
Mao M; Yu Q; Huang R; Lu Y; Wang Z; Liao L
Cancer Med; 2020 Jul; 9(14):4980-4990. PubMed ID: 32432377
[TBL] [Abstract] [Full Text] [Related]
3. Highly Expressed Granulocyte Colony-Stimulating Factor (G-CSF) and Granulocyte Colony-Stimulating Factor Receptor (G-CSFR) in Human gastric cancer Leads to Poor Survival.
Fan Z; Li Y; Zhao Q; Fan L; Tan B; Zuo J; Hua K; Ji Q
Med Sci Monit; 2018 Mar; 24():1701-1711. PubMed ID: 29567938
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of pigmentary side effects of taxanes and anthracyclines: an onychoscopic evaluation.
Yorulmaz A; Dogan M; Artuz F; Zengin N
Cutan Ocul Toxicol; 2017 Jun; 36(2):135-139. PubMed ID: 27086693
[TBL] [Abstract] [Full Text] [Related]
